INFINITY PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INFINITY PHARMA
Largest movements
- Current assets +€429,432
up €429,432 (+15.5%), from €2.8m to €3.2m
of which Cash: +€723,364
- Debts +€243,361
up €243,361 (+16.4%), from €1.5m to €1.7m
- Equity +€177,320
up €177,320 (+13.6%), from €1.3m to €1.5m
of which Reserves: +€177,320
- Turnover +€589,197
up €589,197 (+11.3%), from €5.2m to €5.8m
- Taxes -€67,708
down €67,708 (-44.2%), from €153,292 to €85,584
From the 2019 result to the 2020 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2019 | 2020 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,799,046 | €3,215,404 | +€416,358 | +14.9% |
| Fixed assets | 21/28 | €29,926 | €16,852 | -€13,073 | -43.7% |
| Intangible fixed assets | 21 | €7,624 | €2,744 | -€4,880 | -64.0% |
| Tangible fixed assets | 22/27 | €21,937 | €13,744 | -€8,193 | -37.3% |
| Financial fixed assets | 28 | €364 | €364 | = | 0.0% |
| Current assets | 29/58 | €2,769,120 | €3,198,552 | +€429,432 | +15.5% |
| Stocks and contracts in progress | 3 | €882,706 | €680,959 | -€201,747 | -22.9% |
| Amounts receivable within one year | 40/41 | €94,453 | €22,003 | -€72,450 | -76.7% |
| Cash at bank and in hand | 54/58 | €1,762,794 | €2,486,158 | +€723,364 | +41.0% |
| Total equity and liabilities | 10/49 | €2,799,046 | €3,215,404 | +€416,358 | +14.9% |
| Equity | 10/15 | €1,308,224 | €1,485,545 | +€177,320 | +13.6% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €1,208,224 | €1,385,545 | +€177,320 | +14.7% |
| Profit (loss) carried forward | 14 | €2,013,379 | €907,807 | -€1.1m | -54.9% |
| Provisions and deferred taxes | 16 | €7,926 | €3,603 | -€4,323 | -54.5% |
| Amounts payable | 17/49 | €1,482,896 | €1,726,257 | +€243,361 | +16.4% |
| Amounts payable within one year | 42/48 | €1,481,796 | €1,717,657 | +€235,861 | +15.9% |
| Trade debts | 44 | €861,092 | €1,231,723 | +€370,631 | +43.0% |
| Turnover | 70 | €5,234,497 | €5,823,694 | +€589,197 | +11.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €33,129 | €13,073 | -€20,056 | -60.5% |
| Operating profit (loss) | 9901 | €570,860 | €404,614 | -€166,246 | -29.1% |
| Recurring financial income | 75 | €309 | €80 | -€229 | -74.2% |
| Recurring financial charges | 65 | €127,459 | €141,789 | +€14,330 | +11.2% |
| Debt charges | 650 | €20,334 | €15,348 | -€4,985 | -24.5% |
| Profit (loss) for the period before taxes | 9903 | €443,710 | €262,904 | -€180,805 | -40.7% |
| Income taxes | 67/77 | €153,292 | €85,584 | -€67,708 | -44.2% |
| Profit (loss) for the period | 9904 | €290,417 | €177,320 | -€113,097 | -38.9% |
| Profit (loss) for the period to be appropriated | 9905 | €290,417 | €177,320 | -€113,097 | -38.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2019 and 31 December 2020. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.